Copper-Based Drug Clears Alzheimer’s Toxins and Improves Memory
A copper-based drug, Cu(ATSM), has demonstrated the ability to restore the brain’s waste-clearance systems and reduce toxic amyloid-beta protein buildup by 42 percent in laboratory models, according to findings published in ACS Chemical Neuroscience. Researchers at Monash University report that the compound repairs P-glycoprotein (P-gp) pumps at the blood-brain barrier, which are critical for flushing … Read more
